Quick Takeaways
- Kimberly J. Popovits has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $646,690.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Kimberly J. Popovits
- Location
- Redwood City, CA
- Summary
- The estimated net worth of Kimberly J. Popovits is at least $646,690 dollars as of 03 Apr 2026. Kimberly J. Popovits is the Director of Kiniksa Pharmaceuticals International, plc and owns shares of Kiniksa Pharmaceuticals International, plc (KNSA) stock worth about $375.1K. Kimberly J. Popovits is the Director of 10x Genomics, Inc. and owns shares of 10x Genomics, Inc. (TXG) stock worth about $271.6K.
- Signature
- /s/ Stephen Vander Stoep, attorney-in-fact for Kimberly J. Popovits
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Kimberly J. Popovits and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Kiniksa Pharmaceuticals International, plc ($375,125).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Kimberly J. Popovits
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals International, plc | Director | $375,125 | 30 Jul 2025 | ||
| TXG | 10x Genomics, Inc. | Director | $271,565 | 03 Jun 2025 | ||
| EXAS | EXACT SCIENCES CORP | Director | $0 | 23 Mar 2026 | ||
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Director | 01 Apr 2026 | |||
| TLIS | Talis Biomedical Corp | Director | 09 Jun 2023 |
Insider Transactions Reported by Kimberly J. Popovits:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.